This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Gemtesa 75 mg tablets, a medication used to treat overactive bladder. The delivery order is valued at $26,306.83 and has a completion date of November 20, 2024. The contract is a firm fixed-price arrangement, which means the price does not fluctuate. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 2/18/25, 1:50 PM